Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Erectile Dysfunction × 1 year × Clear all

Phase

Phase NA 6 Phase 2 2 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 229 Neoplasms 145 Breast Neoplasms 141 Colorectal Neoplasms 134 Melanoma 109 Neoplasm Metastasis 108 Leukemia, Myeloid, Acute 107 Ovarian Neoplasms 103 Prostatic Neoplasms 101 Recurrence 93 Pancreatic Neoplasms 90 Multiple Myeloma 87 Stomach Neoplasms 80 Lung Neoplasms 79 Squamous Cell Carcinoma of Head and Neck 78 Triple Negative Breast Neoplasms 69 Lymphoma, Non-Hodgkin 69 Lymphoma 69 Glioblastoma 67 Precursor Cell Lymphoblastic Leukemia-Lymphoma 61 Lymphoma, Large B-Cell, Diffuse 60 Carcinoma, Renal Cell 56 Endometrial Neoplasms 53 Advanced Solid Tumor 52 Leukemia, Lymphocytic, Chronic, B-Cell 49 Myelodysplastic Syndromes 47 Leukemia 47 Head and Neck Neoplasms 44 Carcinoma, Hepatocellular 44 Uterine Cervical Neoplasms 43

Interventions

Cell- and Tissue-Based Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01089387 2025-12-04

INSTIN

Institut National de la Santé Et de la Recherche Médicale, France

Phase 1/2 Completed

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡